India bronchitis treatment market is projected to grow at a significant CAGR of around 4.4% during the forecast period (2020-2026). There are several factors that are leading to the growth of the Indian bronchitis treatment market, which includes the rising cases for respiratory diseases, rising industrialization, and expansion of global market players in India. The Government of India is taking utmost steps to cater the rising cases of respiratory diseases, including pneumonia, asthma, bronchitis, and respiratory tract infections. The Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis in adults (INSEARCH) studies the asthma and other respiratory diseases in the country.
Browse the full report description India Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/india-bronchitis-treatment-market
As per the Tobacco Atlas, every year, more than 932,600 Indians die due to tobacco-related diseases. Complacency in the face of the tobacco epidemic insulates the tobacco industry in India and ensures that tobacco's death toll will grow every year. Therefore, with the growth of the tobacco industry, backed by the change in lifestyle and dietary habits, will further augment the incidence rate of respiratory diseases in the country, which in turn, will lead to the growth of the bronchitis treatment market in India.
Market Coverage
Report Elements |
Details |
Study Period |
2019-2026 |
Base year |
2019 |
Forecast period |
2020-2026 |
Segments Covered |
By Technology |
Key Companies Profiled |
Abbott Laboratories, Bayer AG, GlaxoSmithKline
PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected segment
o Recommendations
India Bronchitis Treatment Market – Segmentation
By Technology
o Antibiotics
o Anti-inflammatory drugs
o Bronchodilators
o Others (Mucolytics)
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/india-bronchitis-treatment-market